# Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients

> **NCT01968941** · PHASE3 · COMPLETED · sponsor: **Ontario Clinical Oncology Group (OCOG)** · enrollment: 324 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** Stereotactic Body Radiotherapy (SBRT)
- **RADIATION:** Conventional Radiotherapy (CRT)

## Key facts

- **NCT ID:** NCT01968941
- **Lead sponsor:** Ontario Clinical Oncology Group (OCOG)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-07
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-05
- **Target enrollment:** 324 (ESTIMATED)
- **Last updated:** 2022-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01968941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01968941, "Stereotactic Body Radiotherapy Versus Conventional Radiotherapy in Medically-Inoperable Non-Small Lung Cancer Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01968941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*